1-4 of 4
Kim Rosenthal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2775: A novel immunostimulatory OX40/PD-L1 bivalent bispecific antibody (MEDI1109) for the treatment of patients with cancer

Michael D. Oberst, Srinath Kasturirangan, Clifford Sachs, Catherine Auge, James Moynihan, Raymond Rothstein, James Hair, Francis Neal, Srinivas Mamidi, Shino Hanabuchi, Amanda Watkins, Yanan Zheng, Kim Rosenthal, Daniel J. Freeman, Scott Hammond
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2775.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2775
Published: 01 July 2018
View article
Journal Articles

Abstract 4328: Phenotypic selection for identification of functional antibodies and development of high throughput screening assays.

Carl Hay, Steven Rust, Erin Sult, Lori Clarke, Kim Rosenthal, Sandrine Guillard, David Lowne, Matt Flynn, Lutz Jermutus, Ralph Minter, Robert Hollingsworth, Kris Sachsenmeier
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4328.
DOI: https://doi.org/10.1158/1538-7445.AM2013-4328
Published: 15 April 2013
View article
Journal Articles

Membrane proteomic analyses of ovarian cancer identifies the immune modulators CD70 and B7-H2 as candidate markers of cisplatin response

Sudeepta Aggarwal, Tao He, William Fitzhugh, Kim Rosenthal, Brian Field, Deborah Mesmer, Elizabeth Joseloff, Steven Ruben, Paul Moore
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2430.
Published: 01 May 2008
View article
Journal Articles

The use of mass spectrometry based proteomics to identify cell surface proteins applicable for monitoring drug resistance, response and therapeutic targeting

Elizabeth Joseloff, Kim Rosenthal, Chad Danis, Tao He, Jenny Heidbrink, William FitzHugh, Candy Lee, Karen Van Orden, Steve Ruben, Paul Moore
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 614.
Published: 01 May 2007
View article